Okast LC Tablet contains Levocetirizine 5mg and Montelukast 10mg, a combination formulation used primarily for the management of allergic conditions such as allergic rhinitis and chronic urticaria. Levocetirizine is a third-generation non-sedating antihistamine that selectively inhibits peripheral H1 receptors, thereby reducing symptoms like sneezing, nasal congestion, itching, and rhinorrhea. Montelukast is a leukotriene receptor antagonist that blocks the action of leukotrienes, inflammatory mediators involved in bronchoconstriction, mucus production, and airway edema. The synergistic effect of these two agents provides comprehensive relief from allergic symptoms by targeting multiple pathways of the allergic response. Okast LC is indicated for patients who require both antihistaminic and leukotriene receptor antagonist therapy, especially in cases where monotherapy is insufficient. It is commonly prescribed for seasonal and perennial allergic rhinitis, asthma prophylaxis, and chronic idiopathic urticaria. The tablet should be taken orally, once daily, preferably in the evening, with or without food. Caution is advised in patients with hepatic or renal impairment, and it is contraindicated in individuals with known hypersensitivity to any component. Common adverse effects may include headache, fatigue, and gastrointestinal disturbances. Consultation with a healthcare professional is recommended before initiating therapy.

Dosage & How to Use